首页 正文

A multidisciplinary approach with immunotherapies for advanced hepatocellular carcinoma

{{output}}
Hepatocellular carcinoma (HCC) is a highly aggressive disease that is usually diagnosed at an advanced stage. Advanced HCC has limited treatment options and often has a poor prognosis. For the past decade, tyrosine kinase inhibitors have been the only treatmen... ...